Mind the costs, too : towards better cost-effectiveness analyses of PBF programmes

Chi, Y-Ling and Gad, Mohamed and Bauhoff, Sebastian and Chalkidou, Kalipso and Megiddo, Itamar and Ruiz, Francis and Smith, Peter C (2018) Mind the costs, too : towards better cost-effectiveness analyses of PBF programmes. BMJ Global Health, 3 (5). e000994. ISSN 2059-7908 (https://doi.org/10.1136/bmjgh-2018-000994)

[thumbnail of Chi-etal-BMJGH-2018-towards-better-cost-effectiveness-analyses-of-PBF-programmes]
Text. Filename: Chi_etal_BMJGH_2018_towards_better_cost_effectiveness_analyses_of_PBF_programmes.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (181kB)| Preview


- The evidence surrounding the cost-effectiveness of performance-based financing (PBF) is weak, and it is not clear how PBF compares with alternative interventions in terms of its value for money. - It is important to fill this evidence gap as countries transition from aid and face increasing budget constraints and competing priorities for the use of their domestic resources. - In conducting cost-effectiveness analyses of PBF, researchers should be mindful of the identification, measurement and valuation of costs and effects, provide justification for the scope of their studies, and specify appropriate comparators and decision rules. - We also recommend the use of a reference case to lay out the principles, preferred methodological choices and reporting standards, as well as a checklist.


Chi, Y-Ling, Gad, Mohamed, Bauhoff, Sebastian, Chalkidou, Kalipso, Megiddo, Itamar ORCID logoORCID: https://orcid.org/0000-0001-8391-6660, Ruiz, Francis and Smith, Peter C;